Eloisa Jantus
@eloisajantus.bsky.social
Mother, Daughter, Cancer Researcher
📍2025-2029 ISLB President @UmbertoMalapel1 and Vice President @ElJanLe in the Closing Ceremony - Orlando Congress. A lot of work to do to prepare educational activities, workshops, guidelines and our next congress in Madrid 2026. @christianrolfo.bsky.social @islb.info @yukselurun.bsky.social
🎉 Everything’s Ready—The ISLB Congress Starts Tomorrow! Three days of inspiring talks, hands-on workshops, and amazing networking opportunities are just around the corn 📍 Location: Double Tree Sea World Orland 🕒 Dates: November 1–3 🎯 What’s Coming Up: • Be tunned!!!
Leading the way in lung cancer care—Dr. Natasha Leighl 🇨🇦 joins #ISLB25! Division Head at Princess Margaret Cancer Centre and ISLB Secretary-Elect, she’s a global expert in precision medicine and diagnostics. 🔗 2025.islb.info #MeetTheSpeakers #LiquidBiopsy #OncologyLeadership #CancerResearch
Honored to present the #ISLB25 Lifetime Achievement Award to Dr. Victor Velculescu for pioneering work in cancer genomics & liquid biopsy. His impact has shaped the field—celebrate with us in Orlando. Register: 2025.islb.info #MeetTheAwardees #OncologyLeadership #CancerResearch #LiquidBiopsy
🩸Our Editorial just published in J Thorac Oncol Thrilled to share insights on ctDNA as a dynamic biomarker to refine patient stratification beyond PD-L1 and RECIST. 🔗 doi.org/10.1016/j.jt... E. Jantus-Lewintre, A. Patiño-García, A. Díaz-Lagares @upv.es @islb.info
The abstract deadline for #ISLB25 has been extended to Sept. 26. The Executive Committee was impressed by the level of interest and responded to the many requests for more time. This is your chance to contribute to the global conversation in Orlando! Submit now: 2025.islb.info/call-for-abs...
Dr. Julia Burnier joins #ISLB25 with research that explores circulating molecules in cancer progression and metastasis. At McGill and RI-MUHC, she leads the Liquid Biopsy Lab and Unit, helping identify biomarkers & therapeutic targets that advance cancer care. Learn more: 2025.islb.info
Dr. Daniel De Carvalho brings his expertise in cancer epigenetics to #ISLB25. At Princess Margaret, his lab develops liquid biopsy tools and explores immune responses driven by transposable elements. #MeetTheSpeakers #OncologyScience #EarlyDetection
On-Demand Access for #ISLB25 is now available! Includes all taped scientific sessions. ISLB membership is required to register, and there’s one flat fee - no early or late pricing! Learn more: 2025.islb.info/registration/ #OnDemand #CancerCare #LiquidBiopsy #Oncology
🚨 Just published! Excited to share our latest research article in collaboration with Julián Carretero, on Liquid Biopsy Biomarkers for EGFR-TKI resistance 🩸🧬 Read it here 👉 www.sciencedirect.com/science/arti...
NNMT-driven metabolic reprogramming creates a NAMPT druggable vulnerability and reveals liquid biopsy biomarkers for TKI resistance in EGFR-mutant NSCLC
Lung cancer is the deadliest neoplasia worldwide. Despite the availability of targeted therapies like tyrosine kinase inhibitors (TKIs) for EGFR-drive…
sciencedirect.com
✨ Happy to share our latest publication at Journal of Controlled Release Proud to have contributed to this collaborative research effort, alongside incredible teams from multiple institutions. 📄 Read it here: doi.org/10.1016/j.jc... #DrugDelivery #Nanomedicine @islb.info
📢 Big News from ISLB! The Journal of Liquid Biopsy is Now Indexed in Scopus 🎉 We’re proud to share that the Journal of Liquid Biopsy the official journal of the ISLB has been accepted for indexing on the Scopus platform Congrats to @UmbertoMalapel1 and the editorial board for making this possible
Happy to share our latest publication !!! 🩸🧬International Society of Liquid Biopsy (ISLB) perspective on minimal requirements for ctDNA testing in solid tumors - The Journal of Liquid Biopsy www.journalofliquidbiopsy.com/article/S295...
International Society of Liquid Biopsy (ISLB) perspective on minimal requirements for ctDNA testing in solid tumors
Circulating tumor DNA (ctDNA) testing has transformed precision oncology by enabling the non-invasive detection of actionable mutations. To facilitate broader clinical adoption and improve testing acc...
journalofliquidbiopsy.com
📍 Today, as we celebrate Labor Day, I want to extend my congratulations to all the individuals who drive scientific progress and advance knowledge every day. Keep up the great work! 🧬🧬🧬🧬🧬 @upv.es
International Society of Liquid Biopsy@islb.info · last yr.🎉 Mark Your Calendars! The 7th Annual ISLB Congress is coming to Orlando, Florida 🇺🇸 | Nov 1–3, 2025 🧬🩸 Join scientists, clinicians, and innovators from around the world to shape the future of liquid biopsy. 🗓️ Save the date and be part of this transformative event! 🔗 More info: islb.info
🎉🩸 Thrilled to share that the Journal of Liquid Biopsy is now officially live in PubMed and PMC! A significant step forward for JLB Check it out here: pmc.ncbi.nlm.nih.gov/journals/?te... #LiquidBiopsy #PubMed @christianrolfo.bsky.social @yukselurun.bsky.social @eloisajantus.bsky.social
📍Comida de Fallas con el Laboratorio de Oncología Molecular!!! Que bien lo pasamos trabajando y también disfrutando de estos momentos de relax 🍰🥟
Congratulations to Susana Torres from our eOM group for receiving the 1st GIDO award for lung cancer research projects! 🏆🧬 A truly well-deserved recognition!!!
📢Multicenter In-House Evaluation of an Amplicon-Based Next−Generation Sequencing Panel for Comprehensive Molecular Profiling @digital-science.com 🦋 app.dimensions.ai/details/publ...
Multicenter In-House Evaluation of an Amplicon-Based Next−Generation Sequencing Panel for Comprehensive Molecular Profiling - Dimensions
BackgroundPredicting response to targeted cancer therapies increasingly relies on both simple and complex genetic biomarkers. Comprehensive genomic profiling using high-throughput assays must be evalu...
app.dimensions.ai
🌍🩸ISLB announces the newly elected ISLB Executive Committee for the term November 2025 – 2029: Congratulations! 🚀
📌February 11th, International Day of Women and Girls in Science. 🌟🔬 Let's honor the incredible contributions of women and girls in STEM fields and inspire the next generation of female scientists and innovators. @aseica.bsky.social @islb.bsky.social @christianrolfo.bsky.social
📌Honored to have participated as a speaker at the International Hereditary Cancers Congress in Antalya, Turkey. 🌍 I had the opportunity to discuss the clinical implementation of liquid biopsy, sharing insights on its potential to revolutionize cancer diagnostics and patient care. 🧬🩸 #LiquidBiopsy
Honored to chair the last session at the X Symposium on Liquid Biopsy in Santiago with Dr Alba as Co-Chair, and an outstanding panel including C. Alix Pannabieres, J. Mateo, and Maria Sanchez-Arago, we explored what the next 10 years hold for liquid biopsy. 🌟🩸 Enriching and insightful discussions!
Hello, Bluesky community! 🌟 Excited to share my very first post here. I'll be diving into fascinating topics in science, particularly focusing on biomarkers and liquid biopsy. 🧬🩸 Stay tuned ! #Biomarkers #LiquidBiopsy @christianrolfo.bsky.social @monicafernandes.bsky.social
